Basic and Clinical Research of Pregnancy-Induced Hypertension

Collect Blood Pressure, Blood, Amniotic Fluid, Placenta and Other Samples From Normal Pregnant Women, Patients With Pregnancy-induced Hypertension and Those Who Have Experienced Miscarriage, and Conduct Tests on Them.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07464379

Acronym

BCRPIH

Enrollment

100

Registered

2026-03-11

Start date

2020-01-01

Completion date

2028-12-31

Last updated

2026-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy-induced Hypertension

Brief summary

Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.

Interventions

OTHERno Intervention

observation

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

\- Healthy pregnant women, patients with miscarriage, etc.

Exclusion criteria

* Heart disease, infections, etc. in pregnant women Uncooperative patients

Design outcomes

Primary

Measure	Time frame	Description
PIH	Early pregnancy：Weeks 1 to 12 (the first to third months of pregnancy) ；mid-pregnancy：Weeks 13 to 27 (the 4th to 6th month of pregnancy) ；post-delivery period：Weeks 28 to 40 (the 7th to 9th months of pregnancy)；the day of delivery。	the content of GPR18 type macrophages

Secondary

Measure	Time frame	Description
PIH	delivery	Blood pressure

Countries

China

Contacts

CONTACTQian Wang, PHD

wqian84@163.com13587638653

STUDY_CHAIRQian Wang

The Second Affiliated Hospital of wenzhou Medical University Longwan Branch

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026